France
Overseed, a pioneering French biotech enterprise, is forging a unique path in the field of medical cannabis. Founded in 2021, it distinguishes itself as the first company in France to receive an ANSM license for cannabis R&D directed towards pharmaceutical applications. With a slogan that emphasizes its commitment to delivering "Medical cannabis: from seed to purified pharmaceutical grade active ingredients," Overseed combines expertise across genetics, agronomy, organic chemistry, and pharmaceutical production.
The company aims to produce GACP and GMP certified cannabis products, including dried flowers, full spectrum extracts, and purified active ingredients, ensuring robust supply chain sovereignty and product quality.
In July 2024, Overseed secured a strategic €6.70M Series A investment, with backing from UI Investissement and Blast.club. This reflects strong investor confidence in its potential to meet patient and industry demands for quality and locally integrated production solutions.
-logo.jpg "Caesar & Loretz GmbH (Caelo)"){kind=logo}